Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aeterna Medical Solutions Sl

Clinical trials sponsored by Aeterna Medical Solutions Sl, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

AI-Powered trial asks: does adding a second drug cut heart failure risk? Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

AI-Powered trial asks: does adding a second drug cut heart failure risk?

Knowledge-focused Not yet recruiting

This study uses computer simulations to compare two treatment strategies for people with chronic kidney disease and type 2 diabetes. Researchers will model whether adding empagliflozin to finerenone reduces heart failure, hospitalizations, and cardiovascular death more than finer…

Sponsor: Aeterna Medical Solutions SL • Aim: Knowledge-focused

Last updated Aug 21, 2026 00:00 UTC